ESTEEM Study to collect information on DMF utilization and safety

• Research type

  Research Study

• Full title

  A Multicenter, Global, Observational Study to Collect Information on Safety and to Document the Drug Utilization of Tecfidera™ (Dimethyl Fumarate) When used in Routine Medical Practice in the Treatment of Multiple Sclerosis (ESTEEM)

• IRAS ID

  135239

• Contact name

  David Rog

• Contact email

  david.rog@srft.nhs.uk

• Sponsor organisation

  Biogen Idec Research Limited

• Research summary

  This is a Global Observational Study to better characterize the utilisation and safety profile of the new drug Tecfidera™ for the treatment of patients with Multiple Sclerosis (MS). This observational study will therefore help characterise the effectiveness and safety of Tecfidera™ when prescribed under routine medical care.

• REC name

  North West - Liverpool Central Research Ethics Committee

• REC reference

  14/NW/0186

• Date of REC Opinion

  17 Apr 2014

• REC opinion

  Further Information Favourable Opinion